In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Johnson & Johnson

Latest From Johnson & Johnson

Alios Buy Best Forgotten For Johnson & Johnson As RSV Failure Costs It Dear

Johnson & Johnson has suspended Phase IIb trial of its RSV asset written off a further $700m against its RSV candidate that it obtained with its $1.75bn purchase of Alios.

Companies Commercial

Perrigo Says 'Spray Hello' To Beco With UK Brand Revitalization Campaign

Perrigo relaunches OTC nasal sprays under single 'Beco' brand supported by £1.7m multimedia marketing campaign.
Health OTC Drugs

Stada Seeking OTC Acquisitions After Strong 2018 As Private-Equity Owners Begin To Flex Muscles

Germany's Stada is on the look out for consumer health acquisitions globally that can help it reach its ambition to grow faster than the market in 2019. The firm's new private-equity owners are backing CEO Peter Goldschmidt's plan to take the Branded Products division to the next level.
Business Strategies Sales & Earnings

Generic Industry Market Forces May Impact GDUFA III Talks

AAM's Chip Davis said a user fee cut is not in order, but industry consolidation and product launch problems may mean it cannot accept another large increase.
Generic Drugs FDA
See All

Company Information